Ractigen Therapeutics IND application for RAG-1C receives FDA clearance

Pfizer reports positive Phase 3 results for LITFULO in nonsegmental vitiligo

European Commission approves RINVOQ for severe alopecia areata

Incyte's Opzelura approved in European Union for moderate atopic dermatitis

RTW Biotech portfolio company Yarrow Bioscience completes merger

Lupin's Diazepam Injection, USP receives US approval

Auxilium Health changes name to Aeris Biosciences

Saol Therapeutics' SL1009 (DCA) resubmission accepted by FDA

Lantern Pharma advances EMA-cleared Phase 1b/2 bladder cancer trial for LP-184

DifGen Pharmaceuticals' single injection treatment for advanced breast cancer cleared for clinical development

AbelZeta's C-CAR168 registrational Phase II trial in refractory Lupus Nephritis granted FDA clearance

AcuCort secures renewed FDA fee waiver ahead of planned NDA submission

Yarrow Bioscience completes VYNE merger and begins Phase 2 trial of YB-101

NewAmsterdam Pharma and Menarini Group report positive CHMP opinion for obicetrapib monotherapy and obicetrapib/ezetimibe combination

Asymchem's DH2 site completes first FDA inspection for continuous manufacturing of API